OrthoPediatrics corp (NASDAQ: KIDS) kicked off on Friday, down -9.19% from the previous trading day, before settling in for the closing price of $17.95. Over the past 52 weeks, KIDS has traded in a range of $16.59-$32.00.
A company in the Healthcare sector has dropped its sales by -11.79% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -18.15%. With a float of $16.86 million, this company’s outstanding shares have now reached $25.07 million.
OrthoPediatrics corp (KIDS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of OrthoPediatrics corp is 32.77%, while institutional ownership is 67.74%. The most recent insider transaction that took place on Aug 21 ’25, was worth 98,525. In this transaction COO and CFO of this company bought 5,076 shares at a rate of $19.41, taking the stock ownership to the 213,065 shares. Before that another transaction happened on Mar 18 ’25, when Company’s General Counsel and Secretary sold 5,310 for $24.86, making the entire transaction worth $132,007. This insider now owns 110,767 shares in total.
OrthoPediatrics corp (KIDS) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.18 earnings per share (EPS), higher than consensus estimate (set at -0.19) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -18.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.06% during the next five years compared to -11.79% drop over the previous five years of trading.
OrthoPediatrics corp (NASDAQ: KIDS) Trading Performance Indicators
Take a look at OrthoPediatrics corp’s (KIDS) current performance indicators. Last quarter, stock had a quick ratio of 3.43. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.10 in one year’s time.
